VRDN icon

Viridian Therapeutics

13 hedge funds and large institutions have $581K invested in Viridian Therapeutics in 2015 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.

Holders
13
Holders Change
+3
Holders Change %
+30%
% of All Funds
0.34%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
2
Reduced
3
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
HighTower Advisors
1
HighTower Advisors
Illinois
$256K 341,630
Vanguard Group
2
Vanguard Group
Pennsylvania
$130K 172,761
PCM
3
Perkins Capital Management
Minnesota
$77K 103,050 -57,200 -36%
ICAS
4
Investors Capital Advisory Services
Massachusetts
$28K 38,250 +16,000 +72%
VKH
5
Virtu KCG Holdings
New York
$24K 32,239 -12,987 -29%
Citadel Advisors
6
Citadel Advisors
Florida
$21K 28,049 +28,049 New
UBS Group
7
UBS Group
Switzerland
$15K 20,144 +13,777 +216%
Nomura Holdings
8
Nomura Holdings
Japan
$12K 16,100 +16,100 New
Creative Planning
9
Creative Planning
Kansas
$10K 13,165
TDC
10
Thompson Davis & Co
Virginia
$8K 10,500 +10,500 New
Bank of America
11
Bank of America
North Carolina
-62,334 Closed
TSS
12
Two Sigma Securities
New York
-17,923 Closed
TRCT
13
Tower Research Capital (TRC)
New York
$0 28 -599 -96%
Morgan Stanley
14
Morgan Stanley
New York
$0 18 +18 New
Citigroup
15
Citigroup
New York
$0 501 +501 New